223 results
Page 4 of 12
8-K
EX-10.4
91j sgr14t
10 Jul 08
Departure of Directors or Principal Officers
12:00am
8-K
EX-10.2
28k a71f9be8am2
10 Jul 08
Departure of Directors or Principal Officers
12:00am
8-K
EX-10.1
haugnh40honqyeeryph
10 Jul 08
Departure of Directors or Principal Officers
12:00am
8-K
EX-10.3
blxpcebrwelahq3
10 Jul 08
Departure of Directors or Principal Officers
12:00am
S-8
EX-10.1
qzfyj oezjrev8a7
13 Jun 08
Registration of securities for employees
12:00am
S-8
EX-10.1
8i9j 4h02vb
12 Jun 08
Registration of securities for employees
12:00am
8-K
EX-10.1
q0ikdi
24 Mar 08
Acura Pharmaceuticals, Inc. Names
12:00am
8-K
EX-10.1
ex2 3osopz
28 Jan 08
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
jqssog
2 Nov 07
Entry into a Material Definitive Agreement
12:00am
S-3
EX-10.4
hqqdrqx
1 Oct 07
Shelf registration
12:00am
S-3
EX-10.6
wfjv4pz9z 0ja8e0
1 Oct 07
Shelf registration
12:00am
S-3
EX-10.3
hzpl06pwm jwf7sl4
1 Oct 07
Shelf registration
12:00am
S-3
EX-10.5
bucrh iltl
1 Oct 07
Shelf registration
12:00am
8-K
EX-10.2
ga4a webdw7lyi
24 Sep 07
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
bzvqmb8w1uw55n7
24 Sep 07
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
kcntx z12s0sgu
21 Aug 07
Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase Iii Clinical Trial for Lead Aversion® Technology Product Candidate
12:00am